The ASENT Board of Directors is comprised of leaders in Neurotherapeutics from Academia, Industry, Government and Advocacy. Members of our board work to
Officers
PRESIDENT
Thomas P. Sutula, MD, PhD
University of Wisconsin – Madison
TREASURER
O’Neill D’Cruz, MD, MBA
OD Consulting and Neurological Services, PLLC
PAST PRESIDENT
Martha Morrell, MD
Stanford University
Members of the Board
Carole Burns, PhD,
Johns Hopkins Technology Ventures
Enrique Carrazana, MD,
Neurelis
Amy Chappell, MD,
Eliem Therapeutics
Stewart Factor, DO,
Emory University
Gail Farfel, PhD,
Zogenix
Toby Ferguson, MD, PhD,
Biogen
Dietrich Haubenberger, MD,
Neurocrine Biosciences
Aditya Joshi, MD,
Penn Medicine
Bennett Lavenstein, MD,
Children’s National
Steven Schachter, MD,
Harvard Medical School, CIMIT
Dave Shoup,
Curry Rockefeller Group
Sharon Tamir
Karyopharm
Amir Tamiz, PhD,
NINDS
Danilo Vitorovic, MD,
University of Vermont
Kenneth Sommerville, MD,
Consultant
Leave a Reply